609 related articles for article (PubMed ID: 28484963)
1. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.
Sifat AE; Vaidya B; Abbruscato TJ
AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963
[TBL] [Abstract][Full Text] [Related]
2. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
3. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.
Li Y; Zhong W; Jiang Z; Tang X
Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier dysfunction and recovery after ischemic stroke.
Jiang X; Andjelkovic AV; Zhu L; Yang T; Bennett MVL; Chen J; Keep RF; Shi Y
Prog Neurobiol; 2018; 163-164():144-171. PubMed ID: 28987927
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.
Yang C; Hawkins KE; Doré S; Candelario-Jalil E
Am J Physiol Cell Physiol; 2019 Feb; 316(2):C135-C153. PubMed ID: 30379577
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
Jin R; Yang G; Li G
Neurobiol Dis; 2010 Jun; 38(3):376-85. PubMed ID: 20302940
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to vascular protection in ischemic stroke.
Yamashita T; Abe K
Acta Med Okayama; 2011 Aug; 65(4):219-23. PubMed ID: 21860527
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.
Abdullahi W; Tripathi D; Ronaldson PT
Am J Physiol Cell Physiol; 2018 Sep; 315(3):C343-C356. PubMed ID: 29949404
[TBL] [Abstract][Full Text] [Related]
9. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?
Jin X; Liu J; Liu W
Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486
[TBL] [Abstract][Full Text] [Related]
10. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
11. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke.
Spitzer D; Guérit S; Puetz T; Khel MI; Armbrust M; Dunst M; Macas J; Zinke J; Devraj G; Jia X; Croll F; Sommer K; Filipski K; Freiman TM; Looso M; Günther S; Di Tacchio M; Plate KH; Reiss Y; Liebner S; Harter PN; Devraj K
Acta Neuropathol; 2022 Aug; 144(2):305-337. PubMed ID: 35752654
[TBL] [Abstract][Full Text] [Related]
12. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic transformation after ischemic stroke in animals and humans.
Jickling GC; Liu D; Stamova B; Ander BP; Zhan X; Lu A; Sharp FR
J Cereb Blood Flow Metab; 2014 Feb; 34(2):185-99. PubMed ID: 24281743
[TBL] [Abstract][Full Text] [Related]
14. D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.
Wang Y; Wang X; Zhang X; Chen S; Sun Y; Liu W; Jin X; Zheng G
J Cell Mol Med; 2020 Aug; 24(16):9255-9266. PubMed ID: 32627929
[TBL] [Abstract][Full Text] [Related]
15. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
[TBL] [Abstract][Full Text] [Related]
16. Neural Stem Cells for Early Ischemic Stroke.
Hamblin MH; Lee JP
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299322
[TBL] [Abstract][Full Text] [Related]
17. Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke.
Lv J; Hu W; Yang Z; Li T; Jiang S; Ma Z; Chen F; Yang Y
Prog Neurobiol; 2018 Feb; 161():79-96. PubMed ID: 29217457
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.
Sarvari S; Moakedi F; Hone E; Simpkins JW; Ren X
Metab Brain Dis; 2020 Aug; 35(6):851-868. PubMed ID: 32297170
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategy against ischemic stroke with the concept of neurovascular unit.
Ozaki T; Nakamura H; Kishima H
Neurochem Int; 2019 Jun; 126():246-251. PubMed ID: 30946849
[TBL] [Abstract][Full Text] [Related]
20. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
